Log in to save to my catalogue
Log in to save to my catalogue

Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/ref...

| Ask | Become a Library member

Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/ref...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_62769d84c1c34b939c41cd4b6c126603

Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis

About this item

Full title

Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis

Author / Creator

Parrondo, Ricardo D , Sam, Keren , Rasheed, Ahsan , Alegria, Victoria , Sher, Taimur , Roy, Vivek , Chanan-Khan, Asher and Ailawadhi, Sikander

Publisher

United States: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2022-04, Vol.12 (4), p.66-66

Language

English

Formats

Articles

Publication information

Publisher

United States: Nature Publishing Group UK

Subjects

More information

Alternative Titles

Full title

Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_62769d84c1c34b939c41cd4b6c126603

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_62769d84c1c34b939c41cd4b6c126603

Other Identifiers

E-ISSN

2044-5385

DOI

10.1038/s41408-022-00662-0

How to access this item

Log in as a Library member

Full text available

About resource

View in old catalogue

Connecting people and collections